HCA

Business Context and Reporting Period

This summary covers the Annual Report on Form 10-K for HCA Inc. for the fiscal year ended December 31, 2007. HCA is a leading U.S. health care services company operating 169 hospitals (163 general acute care, 5 psychiatric, 1 rehabilitation) and 108 freestanding surgery centers across 20 states and England. The company was taken private in November 2006 via a recapitalization by a group of private investors (Hercules Holding II, LLC), resulting in a significant increase in leverage. As of the filing date, the company's common stock is privately held and not traded on a national exchange.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Consolidated revenues increased 5.4% to $26.9 billion, driven by an 8.3% increase in revenue per equivalent admission, which offset a 2.7% decline in equivalent admissions.
• Profitability Decline: Net income decreased 15.7% to $874 million. This decline was primarily due to a $1.26 billion increase in interest expense resulting from the 2006 recapitalization debt load.
• Bad Debt Provision: The provision for doubtful accounts increased significantly to 11.7% of revenues (from 10.4% in 2006), reflecting a 9.4% increase in same-facility uninsured admissions and higher patient financial responsibility.
• Debt Levels: Total indebtedness remained high at $27.3 billion, though slightly lower than the $28.4 billion recorded in 2006. Interest expense more than doubled year-over-year.
• Non-Operating Items: 2007 results included $471 million in gains on sales of facilities (including the sale of two Switzerland hospitals) and $8 million in investment gains. 2006 results included $442 million in transaction costs related to the recapitalization.

Guidance, Outlook, and Risks

• Outlook: Management expects trends of increasing uninsured emergency room visits and admissions to continue in 2008. Planned capital expenditures for 2008 are expected to approximate $1.8 billion.
• Liquidity: The company maintains $2.5 billion in availability under senior secured credit facilities. Management believes cash flows from operations and available credit will meet liquidity needs for the next 12 months.
• Key Risks:
  • Leverage: High debt levels limit flexibility and increase vulnerability to economic conditions and interest rate fluctuations.
  • Government Reimbursement: Significant exposure to Medicare and Medicaid (approx. 57% of admissions). Risks include payment rate reductions, changes in DRG methodologies (MS-DRGs), and potential cuts to Medicaid funding.
  • Uninsured Accounts: Deteriorating collectibility of patient due accounts and growth in uninsured admissions pose a risk to cash flows.
  • Regulatory Compliance: The company is subject to a Corporate Integrity Agreement (CIA) with the OIG and faces ongoing scrutiny regarding billing practices, fraud, and abuse laws (Anti-kickback, Stark Law).
  • Market Risk: The company holds $745 million in auction rate securities (ARS) which have experienced failed auctions, creating potential liquidity constraints and impairment risks.

Investor Verification Checklist

• Debt Service Coverage: Verify the company's ability to service $2.2 billion in annual interest payments given the decline in operating cash flow.
• Uninsured Patient Trends: Monitor the ratio of uninsured admissions and the provision for doubtful accounts, as these directly impact net margins.
• Medicaid Supplemental Payments: Review the status of Texas Medicaid supplemental payments, as the company has suspended revenue recognition for these amounts pending federal review.
• Auction Rate Securities: Assess the potential for other-than-temporary impairment charges on the $745 million ARS portfolio held by the insurance subsidiary.
• Regulatory Settlements: Track ongoing government investigations and the potential for additional penalties or repayment requirements under the Corporate Integrity Agreement.